14.26
0.07 (0.46%)
| 前收盘价格 | 14.19 |
| 收盘价格 | 14.29 |
| 成交量 | 294,906 |
| 平均成交量 (3个月) | 1,326,893 |
| 市值 | 657,538,944 |
| 市盈率 (P/E TTM) | 10.64 |
| 预期市盈率 (P/E Forward) | 5.36 |
| 价格/销量 (P/S) | 1.37 |
| 股市价格/股市净资产 (P/B) | 1.13 |
| 52周波幅 | |
| 利润日期 | 31 Oct 2024 - 4 Nov 2024 |
| 营业毛利率 | -13.06% |
| 营业利益率 (TTM) | 13.02% |
| 稀释每股收益 (EPS TTM) | -1.98 |
| 季度收入增长率 (YOY) | 2.80% |
| 季度盈利增长率 (YOY) | -26.70% |
| 总债务/股东权益 (D/E MRQ) | 85.97% |
| 流动比率 (MRQ) | 2.25 |
| 营业现金流 (OCF TTM) | 203.84 M |
| 杠杆自由现金流 (LFCF TTM) | 169.56 M |
| 资产报酬率 (ROA TTM) | 4.17% |
| 股东权益报酬率 (ROE TTM) | -11.48% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Pacira BioSciences, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.13 |
|
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 2.15% |
| 机构持股比例 | 114.51% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 39.00 (HC Wainwright & Co., 173.59%) | 购买 |
| 中 | 19.50 (36.79%) | |
| 低 | 16.00 (RBC Capital, 12.24%) | 保留 |
| 平均值 | 23.50 (64.85%) | |
| 总计 | 2 购买, 2 保留 | |
| 平均价格@调整类型 | 17.71 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 04 Dec 2024 | 39.00 (173.59%) | 购买 | 19.09 |
| Barclays | 12 Nov 2024 | 17.00 (19.26%) | 保留 | 16.80 |
| Needham | 08 Nov 2024 | 22.00 (54.33%) | 购买 | 17.24 |
| RBC Capital | 07 Nov 2024 | 16.00 (12.24%) | 保留 | 17.70 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合